Pulmonary tuberculosis in an HIV- and hepatitis C virus-coinfected kidney-pancreas transplant recipient: A case report

Transplantation Proceedings

Volumn 43, Issue 4, 2011, Pages 1206-1209

  Dalla Gasperina, D ^a   Tozzi, M ^a   Astuti, N ^a   Balsamo, M L ^a   Donati, D ^b   Rossi, A ^b   Dionigi, R ^a   Grossi, P A ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; BASILIXIMAB; ETHAMBUTOL; FOSAMPRENAVIR PLUS RITONAVIR; ISONIAZID; LAMIVUDINE; MOXIFLOXACIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; PROTEINASE INHIBITOR; PYRAZINAMIDE; TACROLIMUS;

ADULT; ANTIVIRAL THERAPY; CASE REPORT; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CONFERENCE PAPER; DRUG DOSE REDUCTION; GRAFT REJECTION; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY PANCREAS TRANSPLANTATION; LIVER FUNCTION TEST; LUNG TUBERCULOSIS; MALE; MIXED INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; ANTIVIRAL AGENTS; DIABETIC NEPHROPATHIES; HEPATITIS C; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 79957616418     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.02.050     Document Type: Conference Paper

References (29)

1. Grossi PA: Liver transplantation in HIV-infected individuals. In Renzo Dionigi (ed): Recent Advances in Liver Surgery. Landes Bioscience; Austin, Texas, USA 2009, p 352
2. Stock PG, Barin B, Murphy B, et al: Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 363:2004, 2010
3. Tan-Tam CC, Frassetto LA, Stock PG: Liver and kidney transplantation in HIV-infected patients. AIDS Rev 11:209, 2009
4. Subramanian A, Dorman S, and the AST Infectious Diseases Community of Practice: Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 9(suppl 4):S57, 2009
5. Munoz P, Rodriguez C, Bouza E, et al: Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 40:581, 2005
6. Aguado JM, Torre-Cisneros J, Fortún J, et al: Tuberculosis in solid-organ transplant recipients consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 49:1276, 2009
7. Torre-Cisneros J, Doblas A, Aguado JM, et al: Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 48:1657, 2009
8. Singh N, Paterson DL: Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 27:1266, 1998
9. Peters TG, Reiter CG, Boswell RL: Transmission of tuberculosis by kidney transplantation. Transplantation 38:514, 1984
10. Winthrop KL, Kubak BM, Pegues DA, et al: Transmission of Mycobacterium tuberculosis via lung transplantation. Am J Transplant 4:1529, 2004
11. Centers for Disease Control and Prevention (CDC): Transplantation- transmitted tuberculosis - Oklahoma and Texas, 2007. Morb Mortal Wkly Rep 57:333, 2008
12. Graham JC, Kearns AM, Magee JG, et al: Tuberculosis transmitted through transplantation. J Infect 43:251, 2001
13. Corbett EL, Watt CJ, Walker N, et al: The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163:1009, 2003
14. World Health Organization: Global tuberculosis control: surveillance, planning, financing. WHO Report 2009. Geneva: World Health Organization; 2009
15. Getahun H, Gunneberg C, Granich R, et al: HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis 50:S201, 2010
16. Mycobacterium tuberculosis, in Guidelines for the Prevention and Management of Infectious Complications of Solid Organ Transplantation. Am J Transplant 4(suppl 10):37, 2004
17. Currie AC, Knight SR, Morris PJ: Tuberculosis in renal transplant recipients: the evidence for prophylaxis. Transplantation 90:695, 2010
18. Controlling Tuberculosis in the United States. This Official Joint Statement of the American Thoracic Society, the Centers for Disease Control and Prevention, and the Infectious Diseases Society of America was approved by the ATS Board of Directors, June 2004, the Centers for Disease Control and Prevention, November 2004, and the IDSA Board of Directors, March 2005. Am J Respir Crit Care Med 172:1169, 2005
19. Fishman JA and the ATS Infectiuous Diseases Community of Practice: Introduction: infection in solid-organ transplant recipients. Am J Transplant 9:S3, 2009
20. Izzedine H, Launay-Vacher V, Baumelou A, et al: Antiretroviral and immunosuppressive drug-drug interactions: an update. Kidney Intl 66:532, 2004
21. Frassetto LA, Browne M, Cheng A, et al: Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Am J Transplant 7:2816, 2007
22. Manitpisitkul W, McCann E, Lee S, et al: Drug interactions in transplant patients: what everyone should know. Curr Opin Nephrol Hypertens 18:404, 2009
23. Thomas LD, Miller GG, and the AST Infectious Diseases Community of Practice: Interactions between antiinfective agents and immunosuppressants. Am J Transplant 9(suppl 4):S263, 2009
24. Dromer C, Nashef SA, Velly JF, et al: Tuberculosis in transplanted lungs. J Heart Lung Transplant 12:924, 1993
25. Offermann G, Keller F, Molzahn M: Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment. Am J Nephrol 5:385, 1985
26. Aguado JM, Herrero JA, Gavaldà J, et al: Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Transplantation 63:1278, 1997
27. Burman WJ, Gallicano K, Peloquin C: Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis. Clin Infect Dis 28:419, 1999
28. CDC: USPHS/IDSA guidelines for prevention and treatment of oppurtunistic infections in HIV-infected adults and adolescnts. Morb Mortal Wkly Rep 58(No. RR-10), 2009
29. Blumberg EA, Stock P, and the ATS Infectiuous Diseases Community of Practice: Solid organ transplanatation in the HIV-infected patients. Am J Transplant 9:S131, 2009